Olema Oncology logo

Senior Medical Director, Clinical Development

Olema Oncology
Remote friendly (Cambridge, MA)
United States
$315,000 - $350,000 USD yearly
Medical Affairs

Role Summary

Senior Medical Director, reporting to the SVP of Clinical Development, will serve as the Oncology Physician Lead for palazestrant and play a pivotal role in advancing Olema’s late-stage clinical pipeline. You will guide registration-enabling studies by shaping study design, evaluating clinical data, and engaging with regulatory authorities, investigators, and key opinion leaders. You will partner with experienced physicians and cross-functional teams to ensure scientific rigor, data integrity, and patient-centric decision-making while contributing to biomarker development, publication planning, and external scientific communications. This role may be based in San Francisco, CA or Cambridge, MA and may require up to 20% travel.

Responsibilities

  • Lead registration-enabling studies for palazestrant in combination with other therapies, including study design, regulatory engagement, and investigator collaboration
  • Partner across functions to define and implement clinical development strategies and plans for multiple programs
  • Serve as the primary medical expert and point of contact for clinical and scientific questions across internal and external stakeholders
  • Represent Olema in interactions with investigators, academic collaborators, thought leaders, and regulatory authorities
  • Maintain strong clinical and scientific acumen through ongoing engagement with the oncology community and key scientific meetings

Qualifications

  • MD required
  • Board certification in Oncology, Hematology/Oncology, or related specialty; significant experience in breast cancer may substitute
  • A minimum of 5+ years of direct biotech or pharmaceutical experience in clinical development, with leadership in late-phase studies
  • Strong understanding of breast cancer treatment paradigms; experience with ER+/HER2- disease preferred
  • Proven success in designing, leading, and managing late-phase (registrational) studies in oncology; experience as a PI or academic breast cancer expert is valued
  • Deep understanding of the drug development process and ability to translate strategy into action—meeting milestones, managing budgets, and adapting to change
  • Strong knowledge of GCP, FDA, and EMA/CHMP regulations; familiarity with other global regulatory standards is advantageous
  • Effective leadership in a matrixed environment, influencing without authority and driving cross-functional alignment
  • Exceptional communication skills—able to convey complex clinical data with clarity to scientific and non-scientific audiences
  • Demonstrated problem-solving ability with urgency, focus, and creativity
  • Proven record of building collaborative, high-performing teams and partnerships
  • Highly organized, detail-oriented, and adaptable to fast-paced, evolving priorities

Skills

  • Strategic, decisive, and collaborative leadership
  • Strong communication and credibility with internal and external stakeholders
  • Relationship-building in a dynamic, mission-driven environment
  • Commitment to lifelong learning and continuous professional growth

Education

  • MD required
  • Board certification in Oncology, Hematology/Oncology, or related specialty

Additional Requirements

  • Up to 20% travel